We wished to determine whether decreases in prefrontal glutamate concentrations occur in offspring of parents with bipolar disorder with and at high risk for mania. Sixty children and adolescents, 9-18 years old, of parents with bipolar I or II disorder (20 offspring with established history of mania, "BD", 20 offspring with symptoms subsyndromal to mania, "SS", and 20 healthy controls "HC") were examined using proton magnetic resonance spectroscopy at 3 T to study glutamatergic metabolite concentrations in the anterior cingulate cortex (ACC). A signal for reductions in absolute glutamate concentrations in the ACC was seen in the BD compared with HC and SS groups. No other statistically significant differences among groups were found. Offspring of parents with BD with prior histories of mania may have disruptions in glutamatergic function compared with HC or children at risk for BD who have not yet developed mania. Longitudinal studies are necessary to confirm whether prefrontal glutamate decreases only after the onset of full mania.
Introduction
Bipolar disorder (BD) is associated with high rates of familial transmission, with up to a 70% chance of developing a mood disorder in offspring of bilineally affected parents (Goodwin and Jamison, 1990) . Furthermore, genetic factors play a significant role in pediatric onset BD (Pavuluri et al., 2005) . For example, offspring of bipolar parents have an increased risk of developing pediatric onset BD, compared with patients with BD who have no family history of the disorder (Chang et al., 2003a; DelBello and Geller, 2001) . While the familial risk of BD is well established, potential biomarkers for later illness development in children at familial risk for BD remain unknown.
Glutamate is the central mediator of excitatory synaptic transmission in the mammalian brain (Orrego and Villanueva, 1993) , facilitating learning, memory, and synaptic plasticity. Abnormalities in glutamatergic function have been implicated in individuals with BD and other mood disorders (Sanacora et al., 2008) , who show departures from normal glutamate levels in plasma (Palomino et al., 2007) , serum (Mitani et al., 2006) , cerebrospinal fluid (Hoekstra et al., 2006; Frye et al., 2007a) , and brain tissue (Hashimoto et al., 2007) . Other important indicators that glutamatergic dysfunction may be associated with BD include alterations in glutamate receptors (Scarr et al., 2003; McCullumsmith et al., 2007) and disruptions in glial cells important for regulating the glutamatergic system (Ongür et al., 1998) . One recent case-control study reported that increased gene expression of glutamatergic kainate receptors confer genetic protection from the development of BD (Pickard et al., 2008) , illustrating the role that the glutamatergic system may play as a biological marker mediating the development of BD. These data, together with the strong familiality and the increased incidence of bipolar phenomenology in youth, provide an impetus to investigate whether disruption in glutamatergic function coincides with an increased risk for or early onset of mania.
Several recent studies have implicated altered glutamatergic neurochemistry in key cortico-limbic and cerebellar regions in patients with BD across the lifespan (Michael et al., 2003; Frye et al., 2007b , Moore et al., 2007a Ongür et al., 2008; Shibuya-Tayoshi et al., 2008) . Findings associated with functional (Chang et al., 2004) and structural (Kaur et al., 2005) changes in prefrontal brain regions in children and adolescents with BD suggest underlying cellular and molecular dysfunction at a microscopic level in these regions that warrant further investigation. Several lines of evidence suggest that in BD the anterior cingulate cortex (ACC) is particularly vulnerable to potential disease associated changes such as oxidative stress (Wang et al., 2009) , reductions in volume associated with increased trait impulsivity (Matsuo et al., 2009) , and abnormal functional connectivity to the amygdala during emotional processing (Wang et al., 2009 
